Skip to Main Content

Paper Details

Targeting B7â¿¿H3 through EZH2 inhibition in MYCâ¿¿positive Group 3 medulloblastoma.
Oncol Rep
0
2023
B7 homolog 3, B7H3, EPZ005687, EZH2, EZH2MYC, Group, Group 3 MB, Group 3 medulloblastoma, H3K27me3, MB, MB cells, MYC, MYCamplified, MYCamplified C17, MYCpositive, MYCpositive Group 3 medulloblastoma, cancers, enhancer of zeste homolog 2, medulloblastoma, miR29a, patients, tumor, tumor cell
Author NameAffiliation
Sujatha VenkataramanUniversity of Colorado School of Medicine
Rajeev VibhakarUniversity of Colorado School of Medicine
  • 1 - 2

Datasets

Release 1.2